T 0433/14 (Increasing neurogenesis/NEWRON) of 29.05.2018
- European Case Law Identifier
- ECLI:EP:BA:2018:T043314.20180529
- Date of decision
- 29 May 2018
- Case number
- T 0433/14
- Petition for review of
- -
- Application number
- 03772495.2
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Compounds and methods for increasing neurogenesis
- Applicant name
- Newron Sweden AB
- Opponent name
- Novo Nordisk A/S
Amylin Pharmaceuticals, Inc. - Board
- 3.3.04
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 54Rules of procedure of the Boards of Appeal Art 12(4)Rules of procedure of the Boards of Appeal Art 13(1)
- Keywords
- Novelty - main request (no)
Novelty - auxiliary requests 1-9 and 20 (no)
Late-filed auxiliary request 22 - admitted (no) - Catchword
- -
- Citing cases
- T 2218/16
Order
For these reasons it is decided that:
The appeal is dismissed.